Dimensional Fund Advisors
STML

Dimensional Fund Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History

Dimensional Fund Advisors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,802
Closed -$125K – 3405
2019
Q4 		$125K Buy
+11,802
New +$117K ﹤0.01% 3299
2019
Q1 		– Sell
-185,395
Closed -$1.76M – 3472
2018
Q4 		$1.76M Buy
185,395
+14,275
+8% +$185K ﹤0.01% 2903
2018
Q3 		$2.84M Sell
171,120
-6,611
-4% -$106K ﹤0.01% 2837
2018
Q2 		$2.85M Sell
177,731
-39,398
-18% -$703K ﹤0.01% 2797
2018
Q1 		$3.32M Hold
217,129
– – ﹤0.01% 2749
2017
Q4 		$3.39M Sell
217,129
-2,123
-1% -$28.4K ﹤0.01% 2736
2017
Q3 		$2.43M Buy
219,252
+98,775
+82% +$929K ﹤0.01% 2811
2017
Q2 		$1.11M Buy
120,477
+51,578
+75% +$430K ﹤0.01% 2961
2017
Q1 		$589K Sell
68,899
-10,820
-14% -$98.6K ﹤0.01% 3071
2016
Q4 		$853K Sell
79,719
-2,100
-3% -$25.4K ﹤0.01% 3000
2016
Q3 		$886K Buy
81,819
+47,482
+138% +$386K ﹤0.01% 2964
2016
Q2 		$232K Buy
34,337
+19,658
+134% +$124K ﹤0.01% 3157
2016
Q1 		$68K Buy
+14,679
New +$71.7K ﹤0.01% 3251

Other funds holding STML

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Dimensional Fund Advisors's STML Position: Q1 2020 in Review

Dimensional Fund Advisors sold out of Stemline Therapeutics, Inc. (STML) in Q1 2020, closing a stake of 11,802 shares — an estimated $125K sold.

Dimensional Fund Advisors first reported a position in STML in Q1 2016 and held it in 13 quarters. The position peaked at $3.39M in Q4 2017. 94 funds tracked by Wall St. Rank hold STML as of Q1 2020.

  • Dimensional Fund Advisors reported no remaining Stemline Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,802 Stemline Therapeutics, Inc. shares in Q1 2020, an estimated $125K.
  • Dimensional Fund Advisors first reported a position in Stemline Therapeutics, Inc. in Q1 2016 and held it in 13 quarters.
  • Dimensional Fund Advisors's Stemline Therapeutics, Inc. position peaked at $3.39M in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q1 2020.

Based on Dimensional Fund Advisors's 13F filing for Q1 2020, filed 14 May 2020.